Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Quoin Pharmaceuticals ( (QNRX) ) has shared an update.
Quoin Pharmaceuticals Ltd. held its 2024 Annual General Meeting where shareholders approved amendments to the company’s Articles of Association and compensation programs for key executives. These amendments align with Israeli regulations and Nasdaq rules, potentially impacting shareholder meeting protocols and executive compensation structures. The meeting also saw the election of directors, approval of changes to non-employee directors’ compensation, and the appointment of Marcum LLP as the company’s auditor, reflecting strategic governance and financial oversight adjustments.
More about Quoin Pharmaceuticals
YTD Price Performance: -84.10%
Average Trading Volume: 3,002,031
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $3.94M
For a thorough assessment of QNRX stock, go to TipRanks’ Stock Analysis page.